393 related articles for article (PubMed ID: 29090586)
1. Diagnosis and treatment of
Rabbolini DJ; Chun Y; Latimer M; Kunishima S; Fixter K; Valecha B; Tan P; Chew LP; Kile BT; Burt R; Radhakrishnan K; Bird R; Ockelford P; Gabrielli S; Chen Q; Stevenson WS; Ward CM; Morel-Kopp MC
Platelets; 2018 Dec; 29(8):793-800. PubMed ID: 29090586
[No Abstract] [Full Text] [Related]
2. A family with an MYH9-related disorder with different phenotypes masquerading as immune thrombocytopaenia: an underreported disorder in Taiwan.
Huang YC; Shih YH; Lin CY; Chiu PF; Kuo SF; Lin JS; Shen MC
Int J Hematol; 2020 Dec; 112(6):878-882. PubMed ID: 32712863
[TBL] [Abstract][Full Text] [Related]
3. Familial cases with MYH9 disorders caused by MYH9 S96L mutation.
Murayama S; Akiyama M; Namba H; Wada Y; Ida H; Kunishima S
Pediatr Int; 2013 Feb; 55(1):102-4. PubMed ID: 23409987
[TBL] [Abstract][Full Text] [Related]
4. Clinical, pathological, and genetic analysis of ten patients with MYH9-related disease.
Sun XH; Wang ZY; Yang HY; Cao LJ; Su J; Yu ZQ; Bai X; Ruan CG
Acta Haematol; 2013; 129(2):106-13. PubMed ID: 23207509
[TBL] [Abstract][Full Text] [Related]
5. Nonmuscle Myosin Heavy Chain IIA Mutation Predicts Severity and Progression of Sensorineural Hearing Loss in Patients With MYH9-Related Disease.
Verver EJ; Topsakal V; Kunst HP; Huygen PL; Heller PG; Pujol-Moix N; Savoia A; Benazzo M; Fierro T; Grolman W; Gresele P; Pecci A
Ear Hear; 2016; 37(1):112-20. PubMed ID: 26226608
[TBL] [Abstract][Full Text] [Related]
6. R1933X mutation in the MYH9 gene in May-Hegglin anomaly mimicking idiopathic thrombocytopenic purpura.
Sung CC; Lin SH; Chao TK; Chen YC
J Formos Med Assoc; 2014 Jan; 113(1):56-9. PubMed ID: 23759689
[TBL] [Abstract][Full Text] [Related]
7. Avatrombopag improves thrombocytopenia in MYH9-related disorder following eltrombopag treatment failure.
Arif AR; Zhao M; Chen W; Xue M; Luo S; Wang Y
Platelets; 2022 Nov; 33(8):1307-1311. PubMed ID: 35791514
[TBL] [Abstract][Full Text] [Related]
8. [Patient was wrongly diagnosed and repeatedly treated for immune thrombocytopenia for 50 years].
Cherif H; Greinacher A; Lubenow N
Lakartidningen; 2018 Mar; 115():. PubMed ID: 29533410
[TBL] [Abstract][Full Text] [Related]
9. Haematological characteristics of MYH9 disorders due to MYH9 R702 mutations.
Kunishima S; Yoshinari M; Nishio H; Ida K; Miura T; Matsushita T; Hamaguchi M; Saito H
Eur J Haematol; 2007 Mar; 78(3):220-6. PubMed ID: 17241369
[TBL] [Abstract][Full Text] [Related]
10. R705H mutation of MYH9 is associated with MYH9-related disease and not only with non-syndromic deafness DFNA17.
Verver E; Pecci A; De Rocco D; Ryhänen S; Barozzi S; Kunst H; Topsakal V; Savoia A
Clin Genet; 2015 Jul; 88(1):85-9. PubMed ID: 24890873
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic delay of MYH9-related disorder in Japan.
Sakamoto A; Uchiyama T; Kaname T; Iguchi A; Ohara O; Ishimura M; Onum M; Kunishima S; Ishiguro A
Br J Haematol; 2024 Jun; 204(6):2400-2404. PubMed ID: 38650331
[TBL] [Abstract][Full Text] [Related]
12. MYH9 disorder: Identification and a novel mutation in patients with macrothrombocytopenia.
Natesirinilkul R; Sosothikul D; Komwilaisak P; Pongtanakul B; Narkbunnum N; Yudhasompop N; Mekjarusgool P; Niparuck P; Boonyawat K; Kunishima S; Sirachainan N;
Pediatr Blood Cancer; 2021 Jul; 68(7):e29055. PubMed ID: 33855781
[TBL] [Abstract][Full Text] [Related]
13. A novel MYH9 mutation in a patient with MYH9 disorders and platelet size-specific effect of romiplostim on macrothrombocytopenia.
Yamanouchi J; Hato T; Kunishima S; Niiya T; Nakamura H; Yasukawa M
Ann Hematol; 2015 Sep; 94(9):1599-600. PubMed ID: 26051904
[No Abstract] [Full Text] [Related]
14. Heavy chain myosin 9-related disease (MYH9 -RD): neutrophil inclusions of myosin-9 as a pathognomonic sign of the disorder.
Savoia A; De Rocco D; Panza E; Bozzi V; Scandellari R; Loffredo G; Mumford A; Heller PG; Noris P; De Groot MR; Giani M; Freddi P; Scognamiglio F; Riondino S; Pujol-Moix N; Fabris F; Seri M; Balduini CL; Pecci A
Thromb Haemost; 2010 Apr; 103(4):826-32. PubMed ID: 20174760
[TBL] [Abstract][Full Text] [Related]
15. MYH9 Associated nephropathy.
Furlano M; Arlandis R; Venegas MDP; Novelli S; Crespi J; Bullich G; Ayasreh N; Remacha Á; Ruiz P; Lorente L; Ballarín J; Matamala A; Ars E; Torra R
Nefrologia (Engl Ed); 2019; 39(2):133-140. PubMed ID: 30471777
[TBL] [Abstract][Full Text] [Related]
16. Misdiagnosed MYH9 related inherited macrothrombocytopenia with an inadvertent splenectomy.
Thakral B; Rojanapremsuk T; Saluja K; Eldibany M
Pathology; 2015 Jun; 47(4):377-9. PubMed ID: 25938358
[No Abstract] [Full Text] [Related]
17. A novel de novo MYH9 mutation in MYH9-related disease: A case report and review of literature.
Ai Q; Zhao L; Yin J; Jiang L; Jin Q; Hu X; Chen S
Medicine (Baltimore); 2020 Jan; 99(4):e18887. PubMed ID: 31977897
[TBL] [Abstract][Full Text] [Related]
18. [Usefulness of immunofluorescence analysis of neutrophil nonmuscle myosin heavy chain-A for diagnosing in two sisters with May-Hegglin anomaly].
Kimura N; Matsumoto M; Matsumoto K; Asai N; Kunishima S
Rinsho Ketsueki; 2008 Dec; 49(12):1614-8. PubMed ID: 19110523
[TBL] [Abstract][Full Text] [Related]
19. Congenital thrombocytopenia with nephritis - The first case of MYH9 related disorder in Serbia.
Kuzmanović M; Kunishima S; Putnik J; Stajić N; Paripović A; Bogdanović R
Vojnosanit Pregl; 2014 Apr; 71(4):395-8. PubMed ID: 24783421
[TBL] [Abstract][Full Text] [Related]
20. Establishment of mouse model of MYH9 disorders: heterozygous R702C mutation provokes macrothrombocytopenia with leukocyte inclusion bodies, renal glomerulosclerosis and hearing disability.
Suzuki N; Kunishima S; Ikejiri M; Maruyama S; Sone M; Takagi A; Ikawa M; Okabe M; Kojima T; Saito H; Naoe T; Matsushita T
PLoS One; 2013; 8(8):e71187. PubMed ID: 23976996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
